Trial intelligence / Profile preview

TXA in pediatric limb salvage surgery

NCT04410042Phase 3Terminated

Sponsor
St. Jude Children's Research Hospital
Start
Jan 2021
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in bone cancer, sponsored by St. Jude Children's Research Hospital. Started Jan 2021; status: terminated.

02

Drugs

tranexamic acid
03

Conditions

bone cancer

Beyond the preview

Go deeper on NCT04410042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04410042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call